The claudins have recently been identified as a large family of transmembrane proteins located at tight junctions between epithelial cells; they create the paracellular diffusion barrier and, surprisingly, may also confer channel-like selectivity for passage of solutes through the tissue barrier.
In vertebrates, the movement of solutes, ions and water through epithelial cell layers occurs both across and between individual cells [1, 2] . Both routes display cell-specific and tissue-specific variations in permeability, and together account for the distinct transport properties of each tissue. Studies of the hundreds of channels and transporters on the apical and basolateral membranes of epithelial cells have provided a detailed understanding of solute movements across cells -the transcellular pathway. In contrast, the molecular nature of the between-cell, or paracellular, pathway has remained quite elusive. Major new insights into this pathway have come within the last year, following the identification of the claudin protein family of tight junction proteins [3] [4] [5] [6] . Sixteen distinct claudins -from the Latin claudere, to close -have so far been identified, which differ in their expression patterns. The phenotype of an inherited human disorder associated with a defect in paracellin-1 (claudin-16) strongly suggests that claudins might form ion-selective and solute-selective channels through tight junctions [7] . If this prediction is true, we may soon be able to explain the variable properties of paracellular transport and perhaps gain a better understanding of acquired and inherited diseases of epithelial barriers.
The paracellular epithelial barrier is formed by a continuous intercellular contact called the tight junction. First visualised by electron microscopy in the early 1960s, the paracellular barrier appears as a region of very close cell-to-cell apposition at the apical end of the lateral membrane domain (Figure 1 ). Using the freeze-fracture electron microscopy technique, the contacts appear to be formed by linear rows or polymers of transmembrane proteins, which contact similar rows on adjacent cells and seal the intercellular space. Over the past decade, numerous peripheral membrane proteins have been identified that are associated with the cytoplasmic surface of the junction. Unfortunately, these have shed little light on how the barrier is formed and why it varies among cell types in its electrical tightness and selectivity for solute size and charge (reviewed in [1, 2] ).
The first candidate for being a paracellular-barrierforming protein was occludin, a four-span transmembrane protein located specifically within tight junction fibrils ( Figure 1 ) [8] . Occludin clearly has some functional role in creating the barrier, as transepithelial electrical resistance is increased when occludin is over-expressed in cultured epithelial cell lines (MDCK cells) [9, 10] . Furthermore, occludin is an intercellular adhesion molecule [11] and peptides corresponding to extracellular regions of occludin were found to reduce the electrical barrier when added to cultured epithelia monolayers [12] . Until last year, it seemed that occludin was the main component of the barrier and formed continuous adhesive contacts to seal the paracellular space. Several recent observations have suggested this is not the whole story. First, there is only one occludin gene, and the protein is expressed in essentially all tight junctions; so occludin is unlikely to account for tissue differences in barrier properties. Second, and more compelling, was the observation that embryonic stem cells from which occludin was removed by homologous recombination still showed linear fibrils in freezefracture electron microscopy images and were still capable of forming an intercellular barrier [13] .
Important new insights into how the intercellular barrier is formed have come from a remarkable series of papers from Tsukita's group, beginning with the identification of claudin-1 and claudin-2 in 1998 [3] . Claudins are small transmembrane proteins, about 20-22 kDa, which span the membrane four times; by immuno-electron microscopy, they are located within the continuous linear fibrils of the tight junction. The intrinsic ability of claudins to form the linear fibrils was revealed when they were expressed in fibroblasts, which do not normally produce claudin and occludin or make tight junctions [3] . The expression of claudin-1 or claudin-2 from transgenes in these cells was found to result in extensive fibril formation, while expression of occludin gave rise to only short, rudimentary fibrils. When coexpressed, occludin is recruited into the more robust fibrils formed by claudin [3] . Finally, claudins were shown to confer significantly higher cell-cell adhesiveness than occludin, giving rise to the idea they are the primary force organising the fibrils [14] .
What is the experimental evidence that claudins actually create the tight junction's physiological barrier? The best support for this has come from the action of a bacterial enterotoxin, CPE, produced by Clostridium perfringens, which binds to claudin-3 and claudin-4 [15] . The socalled CPE receptor, which turns out to be claudin-4, was actually cloned and studied before the claudin family was discovered and the receptor shown to be a tight junction protein. The full-length 35 kDa toxin binds to either claudin-3 or claudin-4 and induces cytotoxicity through an incompletely understood mechanism; a small carboxyterminal fragment of the toxin binds to the claudins with high affinity but is not cytotoxic. Sonoda et al. [15] showed that prolonged exposure of cultured MDCK cells to the non-cytotoxic CPE fragment caused selective removal and degradation of claudin-4 from the junction, simplification of the freeze-fracture fibrils and a dosedependent disruption of the paracellular barrier. In contrast, claudin-1, which is also produced by MDCK cells, was unaffected by the non-cytotoxic CPE fragment, at least as determined by immunolocalization at the light microscopy level.
Will the claudins provide the explanation for why the paracellular barrier differs among cell types and tissues? To do this, they should be a large protein family and show differential expression patterns; early data imply they fulfil both criteria. To date, sixteen claudins have been identified in several vertebrate species. Interestingly, none has been found in invertebrates, which appear to form epithelial barriers in a fundamentally different way. The limited work already done has shown that some of the claudins have highly restricted expression patterns. For example, claudin-5 has been found only in endothelial cells, and in some tissues it is even further restricted to arteries and excluded from veins [5] . This observation suggests a basic molecular difference between the barriers of blood vessels and epithelial cells, perhaps related to the fact that immune cells have to migrate across blood vessel walls into infected or inflamed tissues. Claudin-11 is found only in the tight junctions of Sertoli cells in the testis and in the myelin sheaths of oligodendrocytes in the brain [6] . It has long been known that accessory cells in the nervous system wrap around axons to isolate their ionic environment and accelerate electrical transmission. We now know these seals are a curiously organised form of tight junction.
A spectacular insight into the function of claudins was provided by the discovery that mutations in the gene for paracellin-1 (claudin-16) are the cause of a rare human renal magnesium-wasting syndrome [7] . Paracellin-1 is found predominately in the thick ascending loop of Henle, a tubule segment where the divalent cations magnesium and calcium are resorbed from the tubule, exclusively through a paracellular route and driven by the intraluminal positive electrical potential. When paracellin-1 is absent, magnesium does not exit the tubule but is lost in the urine, and this leads to hypomagnesaemia and seizures [7] . The clinical phenotype is recessive, so both copies of the normal paracellin gene must be absent for paracellular passage of magnesium to fail. The most obvious interpretation of these results is that paracellin-1 functions as a magnesium-selective channel through the tight junction barrier. This is not such a radical idea if we refer back to the physiology literature of the 1950s to 1970s [1] , but has probably been ignored for lack of a rational molecular explanation. Of note, a chronic form of interstitial nephritis in cattle was recently shown to result from mutation of the claudin-16 gene (Y. Sugimoto, personal communication) although the pathophysiological mechanism has yet to be reported.
Where is research on paracellular transport headed? Much work needs to be done to verify that claudins confer differential channel properties on tight junctions. The evidence should come from a combination of mutagenesis, targeted gene inactivation and transgenic animal approaches. The variable chemistry of the extracellular loops of the claudins suggests a way that channels with different specificities could be formed. These experimental approaches will probably be complemented by the discovery of genetic variation in claudins that predisposes individuals to disease or altered epithelial transport function. Given the fundamental role of tight junctions in forming tissue barriers, we can predict the discovery of genetic variation affecting drug absorption and perhaps even transepithelial movement of microbes and antigens. It remains to be determined whether claudins form homotypic or heterotypic oligomers, and whether different combinations create different channel properties. Despite the recent focus on claudins, the contribution of occludin to the barrier remains unresolved and should not be ignored. A final practical goal will be pharmacological manipulation of claudins and the tight junction barrier in order to alter the transport properties within specific organs for therapeutic purposes.
